Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

AVDL holding history

Avadel Pharmaceuticals PLC in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVDL overviewAll 13F holders of AVDLFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of AVDL by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−273,600−100.0%Sold outHolders
Q4 2025273,600$5.90M<0.1%−282,500−50.8%ReducedHolders
Q3 2025556,100$8.49M<0.1%+302,500+119.3%AddedHolders
Q2 2025253,600$2.24M<0.1%−87,400−25.6%ReducedHolders
Q1 2025341,000$2.67M<0.1%−46,800−12.1%ReducedHolders
Q4 2024387,800$4.08M<0.1%+366,300+1,703.7%AddedHolders
Q3 202421,500$282.0K<0.1%−42,896−66.6%ReducedHolders
Q2 202464,396$905.4K<0.1%−341,610−84.1%ReducedHolders
Q1 2024406,006$6.86M<0.1%−219,100−35.1%ReducedHolders
Q4 2023625,106$8.83M<0.1%−113,800−15.4%ReducedHolders
Q3 2023738,906$7.61M<0.1%+46,800+6.8%AddedHolders
Q2 2023692,106$11.4M<0.1%−127,648−15.6%ReducedHolders
Q1 2023819,754$7.51M<0.1%+133,948+19.5%AddedHolders
Q4 2022685,806$4.91M<0.1%−103,100−13.1%ReducedHolders
Q3 2022788,906$3.95M<0.1%−65,100−7.6%ReducedHolders
Q2 2022854,006$2.08M<0.1%+99,700+13.2%AddedHolders
Q1 2022754,306$5.15M<0.1%−91,500−10.8%ReducedHolders
Q4 2021845,806$6.83M<0.1%−7,500−0.9%ReducedHolders
Q3 2021853,306$8.36M<0.1%−23,200−2.6%ReducedHolders
Q2 2021876,506$5.90M<0.1%−52,800−5.7%ReducedHolders
Q1 2021929,306$8.40M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.